Related Experiment Video
Updated: Jun 26, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Responsiveness to levodopa in epsilon-sarcoglycan deletions
Marta San Luciano1, Laurie Ozelius, Katherine Sims
1Department of Neurology, Beth Israel Medical Center, New York, New York 10003, USA.
Summary
Myoclonus-dystonia (M-D), often caused by SCGE gene mutations, involves involuntary muscle movements. Two patients with SCGE deletions responded well to levodopa (L-dopa) treatment, suggesting its potential therapeutic use.
Area of Science:
- Genetics and Neurology
- Molecular Biology
Background:
- Myoclonus-dystonia (M-D) is a genetic disorder characterized by early-onset involuntary muscle contractions.
- Mutations in the epsilon-sarcoglycan gene (SCGE) at 7q21 are a common cause of M-D.
- The underlying mechanisms of M-D pathogenesis remain unclear, with some models suggesting dopaminergic hyperactivity.
Observation:
- Two unrelated patients with M-D resulting from SCGE deletions were studied.
- These patients exhibited a significant and lasting positive response to levodopa (L-dopa) treatment.
Findings:
- Levodopa (L-dopa) treatment demonstrated efficacy in managing M-D symptoms in patients with SCGE deletions.
- The observed response to L-dopa contrasts with hypotheses derived from murine models suggesting dopamine-blocking agents.
Implications:
- This study suggests that levodopa (L-dopa) may be a viable therapeutic option for patients diagnosed with myoclonus-dystonia.
- Clinical consideration of L-dopa treatment is proposed for M-D patients, challenging previous therapeutic assumptions based on animal models.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...